Archives: 2/2011

04ifmwtj OnControl Bone Marrow System Proves Itself in Multiple Studies
Vidacare of Shavano Park, Texas is touting results of three studies just presented at the annual meeting of the American Society of Hematology in Orlando, Florida that studied the benefits of using the company’s OnControl bone biopsy and aspiration device. f1gzccqn OnControl Bone Marrow System Proves Itself in Multiple StudiesThe long and short of these studies is that the device is faster to use, less painful on the patient, and results in a significantly larger specimen size (see side image) than traditional manual corking.
Here’s a summary of results from Study 1:

  • 124% faster procedure time for OnControl when compared to Manual

  • Significantly lower needle insertion pain (2.6 vs 4.1 on a VAS scale of 0-10)
  • Significantly larger core biopsy specimen with mean volume for OnControl at 36.8mm compared to 15.3mm for Manual
  • Significantly larger core biopsy specimen with mean usable area for OnControl at 25.4mm compared to 11.9mm for Manual.
  • Study 2:

  • 100% core biopsy sample core capture rate for OnControl compared to 67% for manual

  • 83% faster procedure time for OnControl when compared to manual
  • Significantly lower overall pain (20.9 vs 33.3 on a VAS scale of 0-100)
  • Significantly larger core biopsy specimens with a mean volume for OnControl of 49.12mm compared to 10.76mm for manual.
  • Study 3

  • 109% faster procedure time for OnControl compared to Manual

  • Significantly more OnControl patients were pain free 24 hours after the biopsy procedure; 67%
    compared to 33% for Manual patients

  • Significantly larger core biopsy specimens with a mean volume for OnControl of 36.8mm compared
    to 20.4mm for Manual.

  • More details in the press release: Studies Show New Bone Marrow Biopsy Technology Delivers Superior Samples, Less Pain when Compared to Manual Devices…
    Product page: OnControl…

    2np8ibqg Smart Wheelchair to Prevent Injury in Future Wheelchair Designs
    Frazer-Nash has partnered with University College London (UCL) and the Royal National Orthopaedic Hospital Trust (RNOH) to study how wheelchair users use their arms. They’ve built a special wheelchair that can detect the force applied to the wheels and the plan is to use the device to develop new designs that help prevent repetitive rotator cuff damage and other upper extremity problems.

    The wheelchair prototype is based on a previous design called the Powerwheel, which was developed by Frazer-Nash for UK Sport as a training device to improve the performance of Paralympic athletes. Frazer-Nash is working with the RNOH, led by Dr Simon Grange, to understand the needs of NHS wheelchair users and adapt the Powerwheel’s design principles. Innovations such as integrating spoked rather than carbon fibre racing wheels means that the prototype can be used to benefit the rehabilitation and training needs of NHS patients, minimising secondary injuries. Mr Peter Smitham (UCL) will supervise the clinical study at RNOH in collaborating with Frazer-Nash.
    The new wheel design, which is currently undergoing trials at UCL’s PAMELA centre, is fully instrumented and provides real time feedback to the researcher on indicators such as the user’s push force. Frazer-Nash and UCL are collaborating on this research project to investigate the correlation between muscle activity in the shoulder with the push profile exerted by the wheelchair user. It is hoped that this will provide information on the levels of force and specific manoeuvres that could lead to potential damage to the shoulder.

    Link: Frazer-Nash Develops Wheelchair Technology to Aid Rehabilitation of NHS…

    918au960 Accurate and Robust pH Sensor Made From Hydrogels
    Purdue University researchers are developing a new hydrogel pH sensor that’s based on a fairly simple design. Depending on the acidity of the environment the sensor is in, thin strips of hydrogel will contract or expand to specific sizes. The sizes of the hydrogel strips are measured precisely with a laser, creating a unique diffraction pattern, somewhat analogous to how a compact disc works. The diffraction patterns can be translated to a precise pH value.
    Not only is the design simple, but the researchers are touting the new sensor as more practical: low-cost, highly sensitive, and extremely robust. Such sensors could be used in a variety of chemical and biological applications, such as environmental monitoring in water and glucose monitoring in blood.
    Article @ Purdue University: Hydrogels used to make precise new sensor…
    Abstract or Full paper

    Pushing further the possibilities of what one can do with the $150 Microsoft’s Kinect 3D controller, engineers from Johns Hopkins University managed to hook up a Kinect as an interface for a da Vinci surgical robot. See for yourself:

    Nicolas Padoy, from the CIRL laboratory, has demonstrated in a youtube video how to perform a needle insertion as well as other fine manipulation tasks using a kinect and a surgical da Vinci robot used here for non-clinical research.
    The 3D positions of his hands are tracked using depth information obtained from the kinect and are used to control the 3D pose of the robotic tool. This approach allows to translate the 3 degrees of freedom of his hands into gestures which can control a device that has 6 degrees of freedom.
    He uses the system to perform needle insertion on a suturing pod and also to grasp and transfer 6mm plastic rings between spikes.
    All that is missing is a comfortable chair for the surgeon and a 3D screen that gives him full depth-perception of the surgical environment.
    One can imagine that better human-machine interactions will arise with the combination of multiple kinects.

    Flashbacks: Microsoft Kinect 3D Camera for Hands-Free Radiologic Image Browsing; Kinect Hacked to Give Force Feedback During Robotic Surgery; Xbox Kinect Used to Display Realtime 3D CT Recon Data; Kinect-Powered Surgical Robot to Replace Scrub Nurses?

    9crodpzz PEPID Now Available for iPadPEPID mobile platform is now available on the Apple iPad and can run the entire suite of PEPID clinical reference products. Apparently the beta testers recruited last October “widely praised and accepted’ the app. This makes PEPID now available on all iOS devices as well as Android, BlackBerry, Windows Mobile and Palm.

    PEPID is recognized as having the most extensive drug database on the market today, along with thousands of disease profiles and medical conditions, medical and dosing calculators, a drug interaction checker, illustrations, laboratory values and a symptom checker — all of which are now available for the Apple iPad.
    “The new PEPID iPad application takes advantage of the device’s large screen and intuitive user interface,” says Edward Reynolds, chief technology officer. “Our tab navigation interface easily allows healthcare professionals to check for interactions, diagnose a patient, look up diseases and clinical conditions or find proper dosing quickly and easily.”

    Press release: PEPID® Launches Its Application for the Apple iPad®…
    Product page: PEPID on iPad…
    Flashback: PEPID on iPad Signing Up Beta Users, Full Release Coming Soon

    o915okxw Beauty Lift High Nose Electric Nose Lift
    Plastic surgeons beware: here is a small device that wants to compete with your expensive rhinoplasties! The Beauty Lift nose lift is a little gadget from Japan which uses vibrations that are applied from the bottom, side and front of the nose to get that perfect profile. Just three minutes a day is said to be enough. Selling price is $144 , which is a blast compared with rhinoplasty costs. And while you are at it, the same company is selling the Beauty Bottom butt shaping cushion, the Beau Bust Roller, which stimulates breast growth, and, most amazingly, the Pee Without Noise Stool!
    Link: Japan Trend Shop…
    (hat tip: Engadget)

    gfgz7owd New Method Combines MRI, HIFU, Temperature Sensitive Liposomes for Chemo Delivery Directly to Tumor
    Scientists from Eindhoven University of Technology (TU/e) and Philips Research successfully tested a method of delivering doxorubicin (Adriamycin) chemotherapy agent encapsulated within temperature-sensitive liposomes (TSLs) to tumor sites. Magnetic resonance imaging was used to adjust a high intensity focused ultrasound (HIFU) machine to heat the target area and activate the release of doxorubicin from the liposomes.
    ck1gooa8 New Method Combines MRI, HIFU, Temperature Sensitive Liposomes for Chemo Delivery Directly to Tumor
    From a statement by TU/e:

    In pre-clinical studies using their local drug delivery proof-of-concept system designed for the treatment of certain types of tumors, Philips and TU/e achieved an increased chemotherapy drug dose at the tumor site. Some tumors contain sections poorly supplied with blood, which means that chemotherapy drugs are then not taken up evenly in the tumor. As a result, some regions receive sub-optimal doses and are therefore not effectively treated with chemotherapy. Methods for visualizing and measuring drug uptake in the tumor at time of delivery were demonstrated in the pre-clinical investigations. Such information may give an indication directly after the treatment if drug uptake was sufficient. Based on this additional information, tumors that did not receive a sufficient drug dose due to their morphology may be candidates to receive an alternative therapy.
    Philips and TU/e have been working together in this exploratory research, which is also part of the EU-funded (Framework 7) European Research project ‘Sonodrugs’, for two years. The work was performed in a designated joint infrastructure in Eindhoven. Grüll and his team used a combination of MRI and ultrasound technologies together with tiny temperature sensitive drug carrying particles (called liposomes) for local chemotherapy drug delivery. The liposomes, injected into the bloodstream, transport the drug around the body and to the tumor. The latter is mildly heated using a focused ultrasound beam causing the temperature-sensitive liposomes in the tumor to release their drug payload. Simultaneous MR imaging is used to locate the tumor, measure local tissue temperature and guide the ultrasound heating. In order to monitor the amount of drug released, the liposomes also contain a clinically used MRI contrast agent which is co-released on heating. The release of the contrast agent can be monitored with MRI, allowing correlated measurements and visualizations of drug uptake in the tumor and surrounding tissue.


    Full story: Proof of concept of new cancer treatment technology…
    Abstract in Journal of Controlled Release: Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: An in vivo proof-of-concept study

    vuz93x7j Study Shows Efficacy of Tissue Engineered Vascular Grafts
    In a study sponsored by Humacyte (Morrisville, NC), researchers from Duke University, 9ynmy57z Study Shows Efficacy of Tissue Engineered Vascular GraftsEast Carolina University, Yale University, and Humacyte have shown some promising results with tissue-engineered vascular grafts (TEVGs). TEVGs are bioengineered veins that can be used for coronary artery bypass graft surgery and vascular access for hemodialysis. The veins, with a diameter of 3 to 6 mm, were generated in a bioreactor using human and canine smooth muscle cells, decellularized, and stored up to 12 months in refrigerated conditions. After that the veins were implanted in nine adult male baboons and five mongrel dogs. They showed excellent blood flow and resistance to dilatation, calcification and intimal hyperplasia, meaning less chance of occlusion. With this technique, patients who do not have suitable veins of their own could be helped with donor material. One donor could produce grafts for multiple patients. Being tested on animals, this is still in early development, but the results are hopeful. Results were published in the journal Science Translational Medicine.


    Press release: Bioengineered veins offer new hope on horizon for patients lacking healthy veins for coronary bypass surgery or dialysis…
    Article abstract: Readily Available Tissue-Engineered Vascular Grafts…

    kmue5chc Firefly Protein Is an Efficient Source of Near Infrared LightResearchers from Connecticut College have been experimenting with luciferase enzyme, the stuff that makes the abdomen of fireflies glow, as a potential agent for generation of near-infrared (nIR) light. This was accomplished by labeling a luciferase variant with nIR fluorescent dyes. The method was used to detect small amounts of blood factor Xa, a coagulation factor inhibited by antithrombin III during heparin therapy, hence the idea this this technology might be used to monitor coagulation.
    From an abstract in Bioconjugate Chemistry:

    Bioluminescence and bioluminescence resonance energy transfer (BRET) are two naturally occurring light emission phenomena that have been adapted to a wide variety of important research applications including in vivo imaging and enzyme assays. The luciferase enzyme from the North American firefly, which produces yellow−green light, is a key component of many of these applications. Recognizing the heightened interest in the potential of near-infrared (nIR) light to improve these technologies, we have demonstrated that spectral emissions with maxima of 705 and 783 nm can be efficiently produced by a firefly luciferase variant covalently labeled with nIR fluorescent dyes. In one case, an outstanding BRET ratio of 34.0 was achieved emphasizing the importance of selective labeling with fluorescent dyes and the efficiency provided by the intramolecular BRET process. Additionally, we constructed a biotinylated fusion protein that similarly produced nIR light. This novel material was immobilized on solid supports containing streptavidin, demonstrating, in principle, that it may be used for receptor-based imaging. Also, the matrix-bound labeled fusion protein was used to measure factor Xa activity at physiological concentrations in blood. We believe this to be the first report of bright nIR light sources produced by chemical modification of a beetle luciferase.

    Link: Firefly protein lights pathway to improved detection of blood clots…
    Abstract in Bioconjugate Chemistry: Chemically Modified Firefly Luciferase Is an Efficient Source of Near-Infrared Light
    Image credit: James Jordan…